Showing results (1501-1510 of 1,686) with videos related to
Sort By:
Pageof 169
Bioinformatics and Biology Insights|October 24, 2013
On Crowd-verification of Biological Networks, Sam Ansari, Jean Binder, et al.Biology of Reproduction|March 25, 2016
Luteinizing Hormone Causes Phosphorylation and Activation of the cGMP Phosphodiesterase PDE5 in Rat Ovarian Follicles, Contributing, Together with PDE1 Activity, to the Resumption of MeiosisJeremy R Egbert, Tracy F Uliasz, Leia C Shuhaibar, et al.The Annals of Thoracic Surgery|November 20, 2020
The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve ReplacementMubashir Mumtaz, Moritz C Wyler von Ballmoos, G Michael Deeb, et al.Current Problems in Cardiology|July 15, 2022
Cardiac Arrest in Young Adults With Ischemic Heart Disease in the United States, 2004-2018Vardhmaan Jain, Abdul Mannan Khan Minhas, Neal S Kleiman, et al.Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.International Journal of Cardiology|April 13, 2013
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromesRenato D Lopes, Jennifer A White, Dan Atar, et al.Circulation|June 14, 2000
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14S A Coulter, C P Cannon, K A Ault, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 7, 2020
Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statementPinak B Shah, Frederick G P Welt, Ehtisham Mahmud, et al.Pageof 169